Sort
21,281 grants matching “influenza”
Urgent Covid-19 Revision to the Center for High-Throughput Functional Annotation of Natural Products
$241,894John B Macmillan · University Of California Santa Cruz · U41 · FY2020 · AT
Flu-IGIP: Live attenuated influenza virus vaccines with improved stimulation of IgA responses
$241,875Daniel R Perez · University Of Georgia · R21 · FY2019 · AI
Neurobehavioral and molecular studies of gene-environment interactions in schizo
$241,844Mikhail V Pletnikov · Johns Hopkins University · P50 · FY2012 · MH
GENE EXPRESSION PROFILING OF AIDS VACCINE STRATEGIES
$241,779Michael G Katze · University Of Washington · R21 · FY2007 · AI
Isolation And Serotypic Characterization Of Human And Animal Rotaviruses
$241,759Yasutaka Hoshino · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Optimization of AO drugs 45, 51 & 53
$241,738Qi L Lu · Children'S Research Institute · P50 · FY2011 · AR
LASSA FEVER VACCINE EFFICACY IN MARMOSETS
$241,714David H Walker · Texas Biomedical Research Institute · P51 · FY2007 · RR
RSV-induced M2 macrophage differentiation: role of TLR4/PPARg/RXR signaling axis (80)
$241,700Stefanie N. Vogel · University Of Maryland Baltimore · R21 · FY2021 · AI
Mechanism of Azithromycin Activity in Pseudomonas Infections
$241,690Alan R Hauser · Northwestern University At Chicago · R21 · FY2010 · AI
Project II: Immunity to Influenza in Primary Lung Dendritic Cells
$241,685Stuart C. Sealfon · Icahn School Of Medicine At Mount Sinai · U19 · FY2019 · AI
THE FLU-FOBT PROGRAM: TRANSLATION OF AN EVIDENCE-BASED COLORECTAL CANCER SCREENI
$241,650Michael B Potter · University Of California, San Francisco · R18 · FY2010 · DP
T Cell and General Immune Responses to Influenza
$241,594Mark M Davis · Stanford University · U19 · FY2012 · AI
Host-microbe interactions and SARS-CoV-2 susceptibility and symptoms in a novel human challenge model
$241,500Matthew Scott Kelly · Duke University · R21 · FY2023 · AI
Allosteric regulation of a viral RNA-dependent RNA polymerase
$241,500Sarah Marie McDonald Esstman · Virginia Polytechnic Inst And St Univ · R21 · FY2015 · AI
Treating T cell immunodeficiency among older adults by a recombinant Foxn1 fusion protein
$241,500Laijun Lai · University Of Connecticut Storrs · R21 · FY2021 · AG
INHIBITION OF INFLUENZA VIRUS NS1 FUNCTION BY SMALL MOLECULES
$241,497Megan Louise Shaw · Icahn School Of Medicine At Mount Sinai · R21 · FY2009 · AI
Interdisciplinary Training in Virology and Gene Therapy
$241,478Ren Sun · University Of California Los Angeles · T32 · FY2015 · AI
Biophysics of Protein-Mediated Membrane Fusion
$241,424Gregory B Melikian · Emory University · R01 · FY2012 · GM
STRUCTURAL GENOMICS CENTERS FOR INFECTIOUS DISEASES
$241,408Peter Myler · Seattle Children'S Hospital · N01 · FY2020 · AI
Molecular Biology Core
$241,274Lin Liu · Oklahoma State University Stillwater · P20 · FY2022 · GM
DEVELOPMENT OF VSV/HIV RECOMBINANTS AS HIV VACCINES
$241,265Yale University · R01 · FY2001 · AI
Influenza A in the aged: a novel vaccination strategy
$241,250Joy A Phillips · Sidney Kimmel Cancer Center · R21 · FY2007 · AI
Analysis of Host-Pathogen Interactions
$241,185Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Pre-transplant vaccination against pulmonary viral infection
$241,125Dennis M Lindell · Seattle Children'S Hospital · R21 · FY2016 · AI
NATURAL PRODUCT SYNTHESIS VIA CYCLOADDITION REACTIONS
$241,069University Of Michigan At Ann Arbor · R37 · FY2002 · GM